Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
10/07/202406:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:TAKTakeda Pharmaceutical Company Ltd
10/07/202406:15GlobeNewswire Inc.Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience ConferenceTSXV:ASGAurora Spine Corporation
10/07/202406:15Business WireBall Over Everything: NBA® 2K25 Features NBA Champion Jayson Tatum, Two-Time WNBA MVP A’ja Wilson, and Hall-of-Fame Legend Vince Carter as Cover AthletesNASDAQ:TTWOTakeTwo Interactive Software Inc
10/07/202406:15Business WireICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible EmployerNASDAQ:ICLRICON PLC
10/07/202406:15Business WireVanguard Renewables Names Kent Bartley as President of its Organics Solutions Division
10/07/202406:15PR Newswire (US)Redstone Residential selects Funnel as tech backbone for 11,000 owned and third-party managed units
10/07/202406:15PR Newswire (US)WEST LANE CAPITAL PARTNERS ACQUIRES BEAUTY BAKERIE TO ADD TO ITS BEAUTY PLATFORM
10/07/202406:11GlobeNewswire Inc.ALPHAMIN ANNOUNCES RECORD Q2 TIN PRODUCTION OF 4,027 TONNES, UP 28%TSXV:AFMAlphamin Resources Corp
10/07/202406:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PAIYYAesthetic Medical International Holdings Group Ltd (PK)
10/07/202406:10Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:VSTOVista Outdoor Inc
10/07/202406:10PR Newswire (US)Securities Litigation Exposure Increases During Record-Breaking Stock Market
10/07/202406:10PR Newswire (US)FDA Grants PharmassêtX Orphan Drug Designation for Treatment of Rare Form of Inflammatory Bowel Disease with Active Component from Green Tea
10/07/202406:10PR Newswire (US)Nagad partners with Huawei
10/07/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMLXAmylyx Pharmaceuticals Inc
10/07/202406:08Alliance NewsAlliance NewsLONDON MARKET MIDDAY: European stocks recover on US rate hopes
10/07/202406:07Alliance NewsAlliance NewsFeedback partnership to boost offering and commercial opportunitiesLSE:FDBKFeedback Plc
10/07/202406:07Business WireTitanium Ventures Announces Promotions
10/07/202406:07PR Newswire (US)Campers Challenged to Camp Clean This Summer During Great American Campout
10/07/202406:07GlobeNewswire Inc.Emerging Markets Report: Lab Grown Meat Could Spark a RevolutionLN0
10/07/202406:06Alliance NewsAlliance NewsCordel Group inks new customer contract with Genesee & WyomingLSE:CRDLCordel Group Plc
10/07/202406:06Alliance NewsAlliance NewsStarmer looking to strengthen "special relationship" as to meet Biden
10/07/202406:05Business WireTeledyne FLIR Defense Receives $15 Million Contract from NATO Partner for Advanced Weapon SightsNYSE:TDYTeledyne Technologies Inc
10/07/202406:05GlobeNewswire Inc.HBT Financial, Inc. to Announce Second Quarter 2024 Financial Results on July 22, 2024NASDAQ:HBTHBT Financial Inc
10/07/202406:04PR Newswire (US)nShift: The customer experience is more powerful than advertising, say consumers
10/07/202406:03Alliance NewsAlliance NewsUK government prepares for series of meetings to boost EU relations
10/07/202406:03GlobeNewswire Inc.Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
10/07/202406:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:DMDesktop Metal Inc
10/07/202406:01PR Newswire (US)Iridium Receives 2024 James S. Cogswell Outstanding Industrial Security Achievement AwardNASDAQ:IRDMIridium Communications Inc
10/07/202406:01PR Newswire (US)Garmin releases report highlighting cycling trends from around the worldNYSE:GRMNGarmin Ltd
10/07/202406:01PR Newswire (US)Otis Second Quarter 2024 Earnings AdvisoryNYSE:OTISOtis Worldwide Corporation